XPA and skin basal cell carcinoma: Ding et al. [2], in a meta-analysis of 36 studies, found a reduced risk of BCC and SCC in patients affected by XPA-4G>A polymorphism, but nondifferential misclassification bias is somehow possible due to the inclusion in a control group of hospital patients without organic cancer.